Categories
I-CARE Early Covid (187)
I-CARE Flu and RSV (36)
I-PREVENT (153)
I-RECOVER Long Covid (111)
I-RECOVER Post-Vaccine (320)
MATH+ (198)
Tags
ACE2 protein (10)
acute respiratory distress syndrome (14)
Alopecia (7)
Anti-inflammatory (9)
Antidepressants (9)
Ascorbic Acid (12)
autoantibodies (10)
autophagy (24)
Calcifediol (6)
Cancer (9)
Corticosteroids (9)
COVID-19 (270)
COVID-19 Vaccines (8)
Curcumin (8)
Cytokines (12)
Depression (10)
Famotidine (14)
flavonoids (5)
Glucocorticoids (7)
Hydroxychloroquine (12)
Hyperbaric Oxygen Therapy (9)
Inflammation (14)
ivermectin (47)
long COVID (21)
Mast Cells (8)
Melatonin (20)
Methylprednisolone (7)
molnupiravir (5)
N-Acetylcysteine (6)
Non-Invasive Brain Stimulation (8)
Omicron (7)
Oxytocin (8)
Pneumonia (8)
quercetin (15)
SARS-CoV-2 (72)
SARS-CoV-2 mRNA Vaccines (7)
Sepsis (18)
spermidine (11)
Spike Protein (10)
Thiamine (7)
Thrombosis (9)
Tinnitus (12)
Vitamin C (28)
Vitamin D (10)
Zinc (12)
Authors: Sotelo J, Briceno E, Lopez-Gonzalez MA PMID: 16520474 DOI: 10.7326/0003-4819-144-5-200603070-00008 Abstract Background: Malignant cell clones resistant to chemotherapy and radiotherapy frequently lead to treatment failure in patients with glioblastoma multiforme. Preliminary studies suggest that adding chloroquine to conventional therapy may improve treatment outcomes. Objective: To examine the effect of adding chloroquine to conventional therapy [...]
Categories: I-RECOVER Post-Vaccine
